Target intelligence / Profile preview

Serine protease 44, pseudogene (PRSS44P)

Target: PRSS44P
Molecular classification: Other (Pseudogene)

Overview

Serine protease 44, pseudogene (PRSS44P), also known as TESSP4, is listed as a pseudogene in humans, meaning it has lost its protein-coding capability and does not produce a functional protein[2][4]. While the mouse ortholog (Prss44) is a functional testis-specific serine protease expressed during spermatogenesis, its knockout does not affect male fertility in mice, implying redundancy or nonessential function. In humans, PRSS44 is an unprocessed pseudogene, and there is no evidence it serves as a therapeutic target, biomarker, or has any validated biological or disease associations[4].

Other names: PRSS44TESSP-4TESSP4

Beyond the preview

Go deeper on Serine protease 44, pseudogene (PRSS44P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Serine protease 44, pseudogene (PRSS44P).

Explore the full profile